Table 2. Estimated outcomes of 418... | American Society of Hematology

Table 2.

Estimated outcomes of 418 patients achieving CR or PR of at least 75% after induction CTx and randomized for consolidation treatment

Treatment	Patients at risk (%)	CR rate (%)	5-year disease-free survival^*,^†	5-year event-free survival^‡	5-year overall survival^†
MOPP/ABV × 8	92	91	80 ± 4	74 ± 5	85 ± 4
ABVPP × 8	116	99	68 ± 5	67 ± 5	94 ± 3
MOPP/ABV × 6 + RTx	114	95	82 ± 5	78 ± 5	88 ± 4
ABVPP × 6 + RTx	96	91	75 ± 5	66 ± 5	78 ± 4
Total	418	94	75 ± 2	62 ± 2	79 ± 2

Treatment	Patients at risk (%)	CR rate (%)	5-year disease-free survival^*,^†	5-year event-free survival^‡	5-year overall survival^†
MOPP/ABV × 8	92	91	80 ± 4	74 ± 5	85 ± 4
ABVPP × 8	116	99	68 ± 5	67 ± 5	94 ± 3
MOPP/ABV × 6 + RTx	114	95	82 ± 5	78 ± 5	88 ± 4
ABVPP × 6 + RTx	96	91	75 ± 5	66 ± 5	78 ± 4
Total	418	94	75 ± 2	62 ± 2	79 ± 2

Values are means ± SE.

394 patients in CR were analyzed.

P = .01 for the comparison among the 4 treatment arms.

P = .07 for the comparison among the 4 treatment arms.